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1. Introduction
Coronary heart disease is the most common cause of death among adults in developed coun-
tries, and its prevalence is increasing in developing world [1, 2]. Physical inactivity, obesity, 
metabolic disturbances including diabetes mellitus, hypercholesterolemia, and hypertension 
and salty diet, and cigarette smoking are leading to increased vascular diseases [1, 2].
Angiography is still the gold standard diagnostic technique in a majority of vascular diseases. 
The histories of angiography, cardiac catheterization, angioplasty, and modern catheter-
based interventions start in the early eighteenth century. Hales made the first documented 
biventricular catheterization in a horse in 1711 [3]. Then, Forssmann’s right heart self- 
catheterization in 1929 became a milestone in the history of heart catheterization [3]. After suc-
cess in right heart catheterization, researchers focused on left heart, and Zimmerman, Cope, 
Ross, and colleagues achieved left heart catheterization too [3]. The start for coronary angiog-
raphy was given by Sones in 1958 and was followed and developed by Judkins and Amplatz 
via femoral access in angiography [3]. In 1963, Dotter accidentally caused recanalization of a 
peripheral artery with the catheter. In the 1970s, Gruentzig started balloon angioplasty and 
unlocked the door of vascular interventions era [3]. Several technical and industrial develop-
ments allowed us to perform vascular interventions frequently and with great success today.
Current catheter-based interventions are frequently used in cardiology, interventional radiol-
ogy, and neuroradiology for treatment of aortic, coronary, cerebrovascular, and other periph-
eral arterial occlusive and nonocclusive diseases. Interventional therapies are also available 
for a long time in structural heart diseases (e.g., closure of; atrial or ventricular septal defects, 
patent foramen ovale, or left atrial appendage).
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Coronary angiographic interventions evolved from basic left heart catheterization to complex 
interventions including multivessel, bifurcation, left main, and chronic total occlusion thera-
pies. There is a huge amount of industrial materials including differently shaped catheters, 
guidewires, balloons, stents (bare metal and drug eluting), absorbable biovascular scaffolds, 
etc. used in modern catheter laboratories.
On the other hand, the more we understand the coronary physiology, the more we use the 
evidence-based techniques. For example, fractional flow reserve (FFR) allows us to evaluate 
the severity of a coronary stenosis (does the stenosis cause ischemia or not) during coronary 
angiography and guides us whether revascularization is needed [4]. The superiority of FFR-
guided revascularization strategy has been shown in recent trials (DEFER, FAME, and FAME 2) 
over angiography guided strategy [4]. Furthermore, newer techniques not requiring hyper-
emic stimulation, for example, instantaneous wave free ratio (iFR) can be used today for the 
evaluation of coronary stenosis [4].
Intracoronary imaging modalities (intravascular ultrasound (IVUS) and optical coherence 
tomography (OCT)) aim to provide accurate lesion delineation and precise measurements for 
use during angioplasty. It can provide valuable information while choosing the stent size and 
best position for implantation [5, 6]. Nowadays, both IVUS and OCT are more frequently used 
especially during complex coronary interventions (e.g., left main and bifurcation lesions).
Implementation of interventional therapies in daily clinical practice has made the most 
determinant changes in clinical results of coronary heart disease. Angioplasty and stenting 
especially in patients with ST-segment elevation myocardial infarction (STEMI) provided 
important clinical benefits when compared to conventional medical or thrombolytic thera-
pies. At the beginning, angiography was performed via brachial access, then femoral access 
became the access standard, and now radial access is recommended as the most convenient 
access site by the current revascularization guidelines [7–9].
In recent years, scientific researches accumulated more evidence to prefer radial access [7, 8] 
and drug eluting stents (DES) in primary percutaneous interventions [8]. Complex revascu-
larizations during primary percutaneous intervention (PCI) were accepted as contraindicated 
(class III indication) for a long time, but now, the 2017 European Society of Cardiology (ESC) 
revascularization guidelines recommend complete revascularization during index primary 
PCI in STEMI patients in shock with class IIa indication [8]. Another issue, aspiration of blood 
cloth from the occluded vessel during primary angioplasty (thrombus aspiration) is no more 
recommended during primary PCI according to the new guidelines. The use of enoxaparin 
and early hospital discharge are encouraged in patients with STEMI with class IIa indication, 
while former guidelines were recommending it as class IIb indication [8]. Current advance-
ments in lipid lowering therapy have also affected our practice, and additional lipid lowering 
therapy is now recommended (class IIa) if low density lipoprotein levels are over 70 mg/dL 
despite maximum tolerated statin therapy [8].
Current European revascularization guidelines also recommend radial access as standard 
approach in both angiography and PCI, use of DES instead bare metal stents (BMS) in any 
PCI, use of Syntax score in revascularization procedures involving left main coronary artery 
or multivessel disease, use the revascularization strategy preferred among stable coronary 
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artery disease patients in patients with non-STEMI (after stabilization of the patient), use 
of radial artery grafts over saphenous vein grafts in patients with severe coronary stenosis, 
and to prefer CABG surgery for patients with coronary artery disease, heart failure, and left 
ventricular ejection fraction <35% [9].
In this book, we aimed to overview our current diagnostic and therapeutic abilities while using 
angiography in patients with different vascular diseases. Recent developments in interventional 
therapies, drugs, and devices provided us great success in the treatment of vascular diseases 
but we have to learn and progress more. In the future, researchers and developers will keep 
on fighting against atherosclerotic vascular diseases with the aim of decreasing morbidity and 
mortality, providing people a healthy life and protecting the well-being of subjects. However, 
we should not underestimate the value of preventive medicine to achieve more success.
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